2024 annual financial data
Xenon Pharmaceuticals 2024 Operating margin
Xenon Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -279,298,000 USD and net income was -234,330,000 USD.
Operating cash flow was -181,389,000 USD.
Get free Xenon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -279,298,000 USD
- Net income
- -234,330,000 USD
- Operating cash flow
- -181,389,000 USD